A detailed history of Empirical Finance, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Empirical Finance, LLC holds 63,672 shares of ABBV stock, worth $10.6 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
63,672
Previous 61,170 4.09%
Holding current value
$10.6 Million
Previous $9.12 Million 27.16%
% of portfolio
0.72%
Previous 0.67%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $399,869 - $455,614
2,502 Added 4.09%
63,672 $11.6 Million
Q3 2023

Nov 02, 2023

BUY
$133.59 - $154.65 $792,990 - $918,002
5,936 Added 10.75%
61,170 $9.12 Million
Q2 2023

Jul 27, 2023

BUY
$132.51 - $164.9 $813,611 - $1.01 Million
6,140 Added 12.51%
55,234 $7.44 Million
Q1 2023

Apr 05, 2023

BUY
$144.61 - $166.54 $421,827 - $485,797
2,917 Added 6.32%
49,094 $7.82 Million
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $527,929 - $633,125
3,817 Added 9.01%
46,177 $7.46 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $917,727 - $1.05 Million
6,838 Added 19.25%
42,360 $5.69 Million
Q2 2022

Aug 01, 2022

BUY
$137.62 - $174.96 $264,230 - $335,923
1,920 Added 5.71%
35,522 $5.44 Million
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $490,173 - $608,167
3,714 Added 12.43%
33,602 $5.45 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $876,736 - $1.11 Million
8,161 Added 37.56%
29,888 $4.05 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $136,830 - $155,323
1,286 Added 6.29%
21,727 $2.34 Million
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $309,422 - $344,714
2,941 Added 16.81%
20,441 $2.3 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $254,670 - $343,831
3,164 Added 22.07%
17,500 $1.88 Million
Q3 2020

Oct 28, 2020

SELL
$85.91 - $100.83 $814,083 - $955,465
-9,476 Reduced 39.8%
14,336 $1.26 Million
Q3 2020

Oct 26, 2020

SELL
$85.91 - $100.83 $231,527 - $271,736
-2,695 Reduced 10.17%
23,812 $1.8 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $363,108 - $485,892
4,949 Added 22.96%
26,507 $2.6 Million
Q2 2020

Jul 20, 2020

SELL
$73.37 - $98.18 $234,784 - $314,176
-3,200 Reduced 12.93%
21,558 $2.6 Million
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $199,176 - $301,975
3,088 Added 14.25%
24,758 $1.89 Million
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $154,502 - $193,315
-2,142 Reduced 9.0%
21,670 $1.92 Million
Q3 2019

Oct 30, 2019

BUY
$62.98 - $75.72 $1.28 Million - $1.53 Million
20,250 Added 568.5%
23,812 $1.8 Million
Q2 2019

Jul 09, 2019

SELL
$65.7 - $83.98 $4,664 - $5,962
-71 Reduced 1.95%
3,562 $259,000
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $64,103 - $75,446
831 Added 29.66%
3,633 $293,000
Q4 2018

Jan 22, 2019

SELL
$77.85 - $96.01 $18,061 - $22,274
-232 Reduced 7.65%
2,802 $258,000
Q3 2018

Oct 18, 2018

BUY
$88.91 - $98.84 $29,251 - $32,518
329 Added 12.16%
3,034 $287,000
Q2 2018

Jul 09, 2018

SELL
$89.78 - $106.23 $83,315 - $98,581
-928 Reduced 25.54%
2,705 $251,000
Q1 2018

May 10, 2019

BUY
$92.01 - $123.21 $334,272 - $447,621
3,633 New
3,633 $293,000
Q4 2017

Feb 01, 2018

SELL
$89.56 - $98.21 $303,429 - $332,735
-3,388 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $236,651 - $302,277
3,388
3,388 $302,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.